TUTCRIS - Tampereen teknillinen yliopisto

TUTCRIS

Donor-transmitted malignancies in organ transplantation: Assessment of clinical risk

Tutkimustuotosvertaisarvioitu

Standard

Donor-transmitted malignancies in organ transplantation : Assessment of clinical risk. / Nalesnik, M. A.; Woodle, E. S.; Dimaio, J. M.; Vasudev, B.; Teperman, L. W.; Covington, S.; Taranto, S.; Gockerman, J. P.; Shapiro, R.; Sharma, V.; Swinnen, L. J.; Yoshida, A.; Ison, M. G.

julkaisussa: AMERICAN JOURNAL OF TRANSPLANTATION, Vuosikerta 11, Nro 6, 06.2011, s. 1140-1147.

Tutkimustuotosvertaisarvioitu

Harvard

Nalesnik, MA, Woodle, ES, Dimaio, JM, Vasudev, B, Teperman, LW, Covington, S, Taranto, S, Gockerman, JP, Shapiro, R, Sharma, V, Swinnen, LJ, Yoshida, A & Ison, MG 2011, 'Donor-transmitted malignancies in organ transplantation: Assessment of clinical risk', AMERICAN JOURNAL OF TRANSPLANTATION, Vuosikerta. 11, Nro 6, Sivut 1140-1147. https://doi.org/10.1111/j.1600-6143.2011.03565.x

APA

Nalesnik, M. A., Woodle, E. S., Dimaio, J. M., Vasudev, B., Teperman, L. W., Covington, S., ... Ison, M. G. (2011). Donor-transmitted malignancies in organ transplantation: Assessment of clinical risk. AMERICAN JOURNAL OF TRANSPLANTATION, 11(6), 1140-1147. https://doi.org/10.1111/j.1600-6143.2011.03565.x

Vancouver

Nalesnik MA, Woodle ES, Dimaio JM, Vasudev B, Teperman LW, Covington S et al. Donor-transmitted malignancies in organ transplantation: Assessment of clinical risk. AMERICAN JOURNAL OF TRANSPLANTATION. 2011 kesä;11(6):1140-1147. https://doi.org/10.1111/j.1600-6143.2011.03565.x

Author

Nalesnik, M. A. ; Woodle, E. S. ; Dimaio, J. M. ; Vasudev, B. ; Teperman, L. W. ; Covington, S. ; Taranto, S. ; Gockerman, J. P. ; Shapiro, R. ; Sharma, V. ; Swinnen, L. J. ; Yoshida, A. ; Ison, M. G. / Donor-transmitted malignancies in organ transplantation : Assessment of clinical risk. Julkaisussa: AMERICAN JOURNAL OF TRANSPLANTATION. 2011 ; Vuosikerta 11, Nro 6. Sivut 1140-1147.

Bibtex - Lataa

@article{17e7c0b0e6b646ffab222bbc3790748f,
title = "Donor-transmitted malignancies in organ transplantation: Assessment of clinical risk",
abstract = "The continuing organ shortage requires evaluation of all potential donors, including those with malignant disease. In the United States, no organized approach to assessment of risk of donor tumor transmission exists, and organs from such donors are often discarded. The ad hoc Disease Transmission Advisory Committee (DTAC) of the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) formed an ad hoc Malignancy Subcommittee to advise on this subject. The Subcommittee reviewed the largely anecdotal literature and held discussions to generate a framework to approach risk evaluation in this circumstance. Six levels of risk developed by consensus. Suggested approach to donor utilization is given for each category, recognizing the primacy of individual clinical judgment and often emergent clinical circumstances. Categories are populated with specific tumors based on available data, including active or historical cancer. Benign tumors are considered in relation to risk of malignant transformation. Specific attention is paid to potential use of kidneys harboring small solitary renal cell carcinomas, and to patients with central nervous system tumors. This resource document is tailored to clinical practice in the United States and should aid clinical decision making in the difficult circumstance of an organ donor with potential or proven neoplasia. The ad hoc Malignancy Subcommittee of the ad hoc Disease Transmission Advisory Committee of OPTN/UNOS puts forth a framework within which to evaluate organ donor malignancy transmission risk. See editorial by Watson and Bradley on page 1113.",
keywords = "Complications, disease transmission, malignancy, organ donation",
author = "Nalesnik, {M. A.} and Woodle, {E. S.} and Dimaio, {J. M.} and B. Vasudev and Teperman, {L. W.} and S. Covington and S. Taranto and Gockerman, {J. P.} and R. Shapiro and V. Sharma and Swinnen, {L. J.} and A. Yoshida and Ison, {M. G.}",
year = "2011",
month = "6",
doi = "10.1111/j.1600-6143.2011.03565.x",
language = "English",
volume = "11",
pages = "1140--1147",
journal = "AMERICAN JOURNAL OF TRANSPLANTATION",
issn = "1600-6135",
publisher = "Wiley",
number = "6",

}

RIS (suitable for import to EndNote) - Lataa

TY - JOUR

T1 - Donor-transmitted malignancies in organ transplantation

T2 - Assessment of clinical risk

AU - Nalesnik, M. A.

AU - Woodle, E. S.

AU - Dimaio, J. M.

AU - Vasudev, B.

AU - Teperman, L. W.

AU - Covington, S.

AU - Taranto, S.

AU - Gockerman, J. P.

AU - Shapiro, R.

AU - Sharma, V.

AU - Swinnen, L. J.

AU - Yoshida, A.

AU - Ison, M. G.

PY - 2011/6

Y1 - 2011/6

N2 - The continuing organ shortage requires evaluation of all potential donors, including those with malignant disease. In the United States, no organized approach to assessment of risk of donor tumor transmission exists, and organs from such donors are often discarded. The ad hoc Disease Transmission Advisory Committee (DTAC) of the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) formed an ad hoc Malignancy Subcommittee to advise on this subject. The Subcommittee reviewed the largely anecdotal literature and held discussions to generate a framework to approach risk evaluation in this circumstance. Six levels of risk developed by consensus. Suggested approach to donor utilization is given for each category, recognizing the primacy of individual clinical judgment and often emergent clinical circumstances. Categories are populated with specific tumors based on available data, including active or historical cancer. Benign tumors are considered in relation to risk of malignant transformation. Specific attention is paid to potential use of kidneys harboring small solitary renal cell carcinomas, and to patients with central nervous system tumors. This resource document is tailored to clinical practice in the United States and should aid clinical decision making in the difficult circumstance of an organ donor with potential or proven neoplasia. The ad hoc Malignancy Subcommittee of the ad hoc Disease Transmission Advisory Committee of OPTN/UNOS puts forth a framework within which to evaluate organ donor malignancy transmission risk. See editorial by Watson and Bradley on page 1113.

AB - The continuing organ shortage requires evaluation of all potential donors, including those with malignant disease. In the United States, no organized approach to assessment of risk of donor tumor transmission exists, and organs from such donors are often discarded. The ad hoc Disease Transmission Advisory Committee (DTAC) of the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) formed an ad hoc Malignancy Subcommittee to advise on this subject. The Subcommittee reviewed the largely anecdotal literature and held discussions to generate a framework to approach risk evaluation in this circumstance. Six levels of risk developed by consensus. Suggested approach to donor utilization is given for each category, recognizing the primacy of individual clinical judgment and often emergent clinical circumstances. Categories are populated with specific tumors based on available data, including active or historical cancer. Benign tumors are considered in relation to risk of malignant transformation. Specific attention is paid to potential use of kidneys harboring small solitary renal cell carcinomas, and to patients with central nervous system tumors. This resource document is tailored to clinical practice in the United States and should aid clinical decision making in the difficult circumstance of an organ donor with potential or proven neoplasia. The ad hoc Malignancy Subcommittee of the ad hoc Disease Transmission Advisory Committee of OPTN/UNOS puts forth a framework within which to evaluate organ donor malignancy transmission risk. See editorial by Watson and Bradley on page 1113.

KW - Complications

KW - disease transmission

KW - malignancy

KW - organ donation

UR - http://www.scopus.com/inward/record.url?scp=79958794112&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2011.03565.x

DO - 10.1111/j.1600-6143.2011.03565.x

M3 - Review Article

VL - 11

SP - 1140

EP - 1147

JO - AMERICAN JOURNAL OF TRANSPLANTATION

JF - AMERICAN JOURNAL OF TRANSPLANTATION

SN - 1600-6135

IS - 6

ER -